Tags

Type your tag names separated by a space and hit enter

Improving the content uniformity of a low-dose tablet formulation through roller compaction optimization.
Pharm Dev Technol. 2007; 12(4):391-404.PD

Abstract

In this investigation, the potency distribution of a low-dose drug in a granulation was optimized through a two-part study using statistically designed experiments. The purpose of this investigation was to minimize the segregation potential by improving content uniformity across the granule particle size distribution, thereby improving content uniformity in the tablet. Initial operating parameters on the Gerteis 3-W-Polygran 250/100/3 Roller Compactor resulted in a U-shaped potency function (potency vs. granule particle size) with superpotent fines and large granules. The roller compaction optimization study was carried out in two parts. Study I used a full factorial design with roll force (RF) and average gap width (GW) as independent variables and Study II used a D-optimal response surface design with four factors: RF, GW, granulating sieve size (SS), and granulator speed (GS). The planned response variables for Study I were bypass weight % and potency of bypass. Response variables for Study II included mean granulation potency with % relative standard deviation (% RSD), granulation particle size, sieve cut potency % RSD, tablet potency with % RSD, compression force at 7 kP crushing strength, and friability of 7-kP tablets. A constraint on GW was determined in Study I by statistical analysis. Bypass and observations of ribbon splitting were minimized when GW was less than 2.6 mm. In Study II, granulation potency, granulation uniformity, and sieve cut uniformity were optimized when the SS was 0.8 mm. Higher RF during dry granulation produced better sieve cut uniformity and tablets with improved uniformity throughout the run, as measured by stratified tablet samples taken during compression and assayed for potency. The recommended optimum roller compaction and milling operating parameters that simultaneously met all constraints were RF = 9 kN, GW = 2.3 mm, SS = 0.8 mm, and GS = 50 rpm. These parameters became the operating parameter set points during a model confirmation trial. The results from the confirmation trial proved that the new roller compaction and milling conditions reduced the potential for segregation by minimizing the granulation potency variability as a function of particle size as expressed by sieve cut potency % RSD, and thus improved content uniformity of stratified tablet samples.

Authors+Show Affiliations

Pfizer Global Research & Development, Groton, CT, USA. Mary.T.am.Ende@pfizer.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17763144

Citation

am Ende, Mary T., et al. "Improving the Content Uniformity of a Low-dose Tablet Formulation Through Roller Compaction Optimization." Pharmaceutical Development and Technology, vol. 12, no. 4, 2007, pp. 391-404.
am Ende MT, Moses SK, Carella AJ, et al. Improving the content uniformity of a low-dose tablet formulation through roller compaction optimization. Pharm Dev Technol. 2007;12(4):391-404.
am Ende, M. T., Moses, S. K., Carella, A. J., Gadkari, R. A., Graul, T. W., Otano, A. L., & Timpano, R. J. (2007). Improving the content uniformity of a low-dose tablet formulation through roller compaction optimization. Pharmaceutical Development and Technology, 12(4), 391-404.
am Ende MT, et al. Improving the Content Uniformity of a Low-dose Tablet Formulation Through Roller Compaction Optimization. Pharm Dev Technol. 2007;12(4):391-404. PubMed PMID: 17763144.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Improving the content uniformity of a low-dose tablet formulation through roller compaction optimization. AU - am Ende,Mary T, AU - Moses,Sara K, AU - Carella,Anthony J, AU - Gadkari,Rashmi A, AU - Graul,Timothy W, AU - Otano,Angel L, AU - Timpano,Robert J, PY - 2007/9/1/pubmed PY - 2007/11/6/medline PY - 2007/9/1/entrez SP - 391 EP - 404 JF - Pharmaceutical development and technology JO - Pharm Dev Technol VL - 12 IS - 4 N2 - In this investigation, the potency distribution of a low-dose drug in a granulation was optimized through a two-part study using statistically designed experiments. The purpose of this investigation was to minimize the segregation potential by improving content uniformity across the granule particle size distribution, thereby improving content uniformity in the tablet. Initial operating parameters on the Gerteis 3-W-Polygran 250/100/3 Roller Compactor resulted in a U-shaped potency function (potency vs. granule particle size) with superpotent fines and large granules. The roller compaction optimization study was carried out in two parts. Study I used a full factorial design with roll force (RF) and average gap width (GW) as independent variables and Study II used a D-optimal response surface design with four factors: RF, GW, granulating sieve size (SS), and granulator speed (GS). The planned response variables for Study I were bypass weight % and potency of bypass. Response variables for Study II included mean granulation potency with % relative standard deviation (% RSD), granulation particle size, sieve cut potency % RSD, tablet potency with % RSD, compression force at 7 kP crushing strength, and friability of 7-kP tablets. A constraint on GW was determined in Study I by statistical analysis. Bypass and observations of ribbon splitting were minimized when GW was less than 2.6 mm. In Study II, granulation potency, granulation uniformity, and sieve cut uniformity were optimized when the SS was 0.8 mm. Higher RF during dry granulation produced better sieve cut uniformity and tablets with improved uniformity throughout the run, as measured by stratified tablet samples taken during compression and assayed for potency. The recommended optimum roller compaction and milling operating parameters that simultaneously met all constraints were RF = 9 kN, GW = 2.3 mm, SS = 0.8 mm, and GS = 50 rpm. These parameters became the operating parameter set points during a model confirmation trial. The results from the confirmation trial proved that the new roller compaction and milling conditions reduced the potential for segregation by minimizing the granulation potency variability as a function of particle size as expressed by sieve cut potency % RSD, and thus improved content uniformity of stratified tablet samples. SN - 1083-7450 UR - https://www.unboundmedicine.com/medline/citation/17763144/Improving_the_content_uniformity_of_a_low_dose_tablet_formulation_through_roller_compaction_optimization_ L2 - https://www.tandfonline.com/doi/full/10.1080/10837450701369253 DB - PRIME DP - Unbound Medicine ER -